• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同体重分类儿童肠道微生物群和短链脂肪酸水平的横断面比较。

Cross-sectional comparisons of gut microbiome and short-chain fatty acid levels among children with varied weight classifications.

作者信息

Gyarmati Peter, Song Yajing, Dotimas James, Yoshiba Grace, Christison Amy

机构信息

Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, Illinois, USA.

Department of Pediatrics, University of Illinois College of Medicine at Peoria, Peoria, Illinois, USA.

出版信息

Pediatr Obes. 2021 Jun;16(6):e12750. doi: 10.1111/ijpo.12750. Epub 2020 Nov 11.

DOI:10.1111/ijpo.12750
PMID:33174684
Abstract

BACKGROUND

Limited studies associate changes in microbiota composition and metabolites among children and adolescents with obesity. Decreases in compositional diversity, increases in the proportion of Firmicutes and Bacteroidetes (F/B ratio) and increases in short-chain fatty acids (SCFAs) have been proposed as contributing factors in the pathophysiology of obesity.

OBJECTIVES

The aim of the current study was to characterize the faecal microbiota composition, diversity, F/B ratio and SCFA levels in different weight categories (lean, overweight, obesity classes 1-3) of children ages 5 to 12 years.

METHODS

We collected and processed 83 samples from different weight categories (27.7% lean, 11% overweight, 15%, 17% and 17% of obesity classes 1, 2, and 3, respectively). Microbiota content was determined by sequencing the V4 region of the 16S rRNA gene, and SCFA content was analyzed.

RESULTS

Microbiota compositions showed no significant differences in diversity or F/B ratios between weight categories. However, a relative abundance of Proteobacteria and lack of Verrucomicrobia were demonstrated when comparing severe obesity to the leaner groups. Faecal butyrate, propionate and isopentanoate concentrations increased progressively with weight category demonstrating significance in the class 3 obesity group.

CONCLUSIONS

Our results show that severe childhood obesity in our study population was associated with changes in gut microbiome composition correlated to previously reported cardiometabolic disease states in obesity. Increased SCFA levels correlate with obesity-related microbiome metabolic function without a reduction in diversity characterized at a phyla level. Further characterization of these specimens at a species level and longitudinal studies are needed to elucidate these relationships.

摘要

背景

关于肥胖儿童和青少年的微生物群组成及代谢物变化的研究有限。有人提出,组成多样性降低、厚壁菌门和拟杆菌门的比例增加(F/B 比值)以及短链脂肪酸(SCFA)增加是肥胖病理生理学的促成因素。

目的

本研究的目的是描述 5 至 12 岁不同体重类别(消瘦、超重、1 - 3 级肥胖)儿童的粪便微生物群组成、多样性、F/B 比值和 SCFA 水平。

方法

我们收集并处理了来自不同体重类别的 83 个样本(分别为 27.7%消瘦、11%超重、15%、17%和 17%的 1、2 和 3 级肥胖)。通过对 16S rRNA 基因的 V4 区域进行测序来确定微生物群含量,并分析 SCFA 含量。

结果

不同体重类别之间的微生物群组成在多样性或 F/B 比值上没有显著差异。然而,与较瘦的组相比,重度肥胖组中变形菌门的相对丰度较高,疣微菌门缺乏。粪便中丁酸盐、丙酸盐和异戊酸盐的浓度随着体重类别逐渐增加,在 3 级肥胖组中具有显著性。

结论

我们的结果表明,在我们的研究人群中,儿童重度肥胖与肠道微生物群组成的变化有关,这些变化与先前报道的肥胖相关心脏代谢疾病状态相关。SCFA 水平升高与肥胖相关的微生物群代谢功能相关,而在门水平上没有多样性降低的特征。需要在物种水平上对这些样本进行进一步表征以及进行纵向研究来阐明这些关系。

相似文献

1
Cross-sectional comparisons of gut microbiome and short-chain fatty acid levels among children with varied weight classifications.不同体重分类儿童肠道微生物群和短链脂肪酸水平的横断面比较。
Pediatr Obes. 2021 Jun;16(6):e12750. doi: 10.1111/ijpo.12750. Epub 2020 Nov 11.
2
Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations.儿童肥胖与肠道微生物群改变以及厚壁菌门菌群的不协调变化有关。
Environ Microbiol. 2017 Jan;19(1):95-105. doi: 10.1111/1462-2920.13463. Epub 2016 Aug 22.
3
Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors.更高的粪便短链脂肪酸水平与肠道微生物失调、肥胖、高血压和心血管代谢疾病风险因素有关。
Nutrients. 2018 Dec 27;11(1):51. doi: 10.3390/nu11010051.
4
Short-Chain Fatty Acid Production by Gut Microbiota from Children with Obesity Differs According to Prebiotic Choice and Bacterial Community Composition.肠道微生物群产生的短链脂肪酸根据益生菌选择和细菌群落组成在肥胖儿童中存在差异。
mBio. 2020 Aug 11;11(4):e00914-20. doi: 10.1128/mBio.00914-20.
5
Associations between Diet, the Gut Microbiome, and Short-Chain Fatty Acid Production among Older Caribbean Latino Adults.老年加勒比裔拉丁裔成年人饮食、肠道微生物组与短链脂肪酸产生之间的关联。
J Acad Nutr Diet. 2020 Dec;120(12):2047-2060.e6. doi: 10.1016/j.jand.2020.04.018. Epub 2020 Aug 12.
6
The associations of the gut microbiome composition and short-chain fatty acid concentrations with body fat distribution in children.肠道微生物组成和短链脂肪酸浓度与儿童体脂肪分布的关联。
Clin Nutr. 2021 May;40(5):3379-3390. doi: 10.1016/j.clnu.2020.11.014. Epub 2020 Nov 20.
7
Composition of gut microbiota in obese and normal-weight Mexican school-age children and its association with metabolic traits.肥胖和正常体重的墨西哥学龄儿童肠道微生物群的组成及其与代谢特征的关联。
Pediatr Obes. 2018 Jun;13(6):381-388. doi: 10.1111/ijpo.12262. Epub 2017 Dec 5.
8
Associations of Dietary Intake with the Intestinal Microbiota and Short-Chain Fatty Acids Among Young Adults with Type 1 Diabetes and Overweight or Obesity.1型糖尿病合并超重或肥胖的年轻成年人的饮食摄入与肠道微生物群和短链脂肪酸的关联
J Nutr. 2023 Apr;153(4):1178-1188. doi: 10.1016/j.tjnut.2022.12.017. Epub 2022 Dec 27.
9
Characteristics of Gut Microbiome and Its Metabolites, Short-Chain Fatty Acids, in Children With Idiopathic Short Stature.特发性身材矮小儿童的肠道微生物组及其代谢产物(短链脂肪酸)的特征。
Front Endocrinol (Lausanne). 2022 Jun 10;13:890200. doi: 10.3389/fendo.2022.890200. eCollection 2022.
10
Analysis of correlations between gut microbiota, stool short chain fatty acids, calprotectin and cardiometabolic risk factors in postmenopausal women with obesity: a cross-sectional study.绝经后肥胖女性肠道微生物群、粪便短链脂肪酸、钙卫蛋白与心血管代谢危险因素的相关性分析:一项横断面研究。
J Transl Med. 2022 Dec 12;20(1):585. doi: 10.1186/s12967-022-03801-0.

引用本文的文献

1
Synbiotic Effects of Lacticaseibacillus paracasei K56 and Prebiotics on the Intestinal Microecology of Children with Obesity.副干酪乳杆菌K56与益生元对肥胖儿童肠道微生态的合生元效应
Probiotics Antimicrob Proteins. 2024 Nov 6. doi: 10.1007/s12602-024-10395-0.
2
Pre- to Postbiotics: The Beneficial Roles of Pediatric Dysbiosis Associated with Inflammatory Bowel Diseases.益生元到合生元:与炎症性肠病相关的儿童肠道菌群失调的有益作用
Microorganisms. 2024 Aug 2;12(8):1582. doi: 10.3390/microorganisms12081582.
3
Dietary fiber for the prevention of childhood obesity: a focus on the involvement of the gut microbiota.
膳食纤维预防儿童肥胖:关注肠道微生物群的作用。
Gut Microbes. 2024 Jan-Dec;16(1):2387796. doi: 10.1080/19490976.2024.2387796. Epub 2024 Aug 20.
4
Obesity-associated inflammation countered by a Mediterranean diet: the role of gut-derived metabolites.地中海饮食对抗肥胖相关炎症:肠道衍生代谢物的作用
Front Nutr. 2024 Jun 24;11:1392666. doi: 10.3389/fnut.2024.1392666. eCollection 2024.
5
Relationships and Mendelian Randomization of Gut Microbe-Derived Metabolites with Metabolic Syndrome Traits in the METSIM Cohort.METSIM队列中肠道微生物衍生代谢物与代谢综合征特征的关系及孟德尔随机化研究
Metabolites. 2024 Mar 20;14(3):174. doi: 10.3390/metabo14030174.
6
A Novel Bifidobacterium/Klebsiella Ratio in Characterization Analysis of the Gut and Bile Microbiota of CCA Patients.一种新型双歧杆菌/克雷伯氏菌比值在 CCA 患者肠道和胆汁微生物群特征分析中的应用。
Microb Ecol. 2023 Nov 30;87(1):5. doi: 10.1007/s00248-023-02318-3.
7
Mendelian randomization analyses support causal relationship between gut microbiota and childhood obesity.孟德尔随机化分析支持肠道微生物群与儿童肥胖之间的因果关系。
Front Pediatr. 2023 Aug 1;11:1229236. doi: 10.3389/fped.2023.1229236. eCollection 2023.
8
Role of bile acids in overweight and obese children and adolescents.胆汁酸在超重和肥胖儿童及青少年中的作用。
Front Endocrinol (Lausanne). 2022 Nov 30;13:1011994. doi: 10.3389/fendo.2022.1011994. eCollection 2022.
9
Diet-Related Changes of Short-Chain Fatty Acids in Blood and Feces in Obesity and Metabolic Syndrome.肥胖和代谢综合征患者血液及粪便中与饮食相关的短链脂肪酸变化
Biology (Basel). 2022 Oct 24;11(11):1556. doi: 10.3390/biology11111556.
10
Roles of gut microbiota and metabolites in overweight and obesity of children.肠道微生物群和代谢物在儿童超重和肥胖中的作用。
Front Endocrinol (Lausanne). 2022 Sep 8;13:994930. doi: 10.3389/fendo.2022.994930. eCollection 2022.